# AREV Life Sciences Global Corp (AREVF)

> Healthcare · CA · Reports in CAD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/AREVF/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2023 | $ 0 | $ -331.1K | $ -151.9K | $ 145.5K | $ -1.16M |
| 2022 | $ 52.7K | $ -1.55M | $ -392.9K | $ 28.8K | $ -952.6K |
| 2021 | $ 290.0K | $ -1.12M | $ -1.69M | $ 75.7K | $ -93.5K |
| 2020 | $ 227.8K | $ -1.25M | $ -573.4K | $ 736.0K | $ -641.2K |
| 2019 | $ 409.3K | $ -3.84M | $ -396.0K | $ 573.2K | $ -525.8K |
| 2018 | $ 397.0K | $ -11.74M | $ -1.60M | $ 427.7K | $ -226.4K |
| 2017 | $ 0 | $ -1.28M | $ -704.7K | $ 284.7K | $ 959.3K |
| 2016 | $ 0 | $ -318.7K | $ -148.1K | $ 363.4K | $ 183.8K |
| 2015 | $ 0 | $ -109.3K | $ -67.2K | $ 51.8K | $ -164.3K |
| 2014 | $ 0 | $ -99.2K | $ -5.5K | $ 0 | $ -80.2K |
| 2013 | $ 0 | $ -45.5K | $ -38.3K | $ 0 | $ -5.0K |
| 2012 | $ 0 | $ -66.3K | $ 20.2K | $ 0 | $ 29.1K |
| 2011 | $ 141.5K | $ 84.3K | $ 13.4K | $ 0 | $ 78.0K |
| 2010 | $ 55.2K | $ -23.1K | $ -30.3K | $ 25.0K | $ -9.8K |
| 2009 | $ 0 | $ -323.3K | $ -108.6K | $ 0 | $ 6.7K |
| 2008 | $ 434.9K | $ -324.9K | $ -364.1K | $ 0 | $ 232.7K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -0.13 |
| Liabilities / Eq | -1.18 |
| Current Ratio | 0.05 |

## Other views

- [Metrics](https://sponda.capital/en/AREVF.md)
- [Charts](https://sponda.capital/en/AREVF/charts.md)
- [Compare](https://sponda.capital/en/AREVF/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.